25 results
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Drugs for Treatment ... Multidrug-Resistant Tuberculosis ... antimicrobials #pharmacology ... #dosing #idsa #
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA ... Aspergillosis #Treatment ... #pharmacology # ... dosing #medications ... #IDSA #Guidelines
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
- IDSA Guidelines ... #Tuberculosis ... #medications #pharmacology ... #IDSA #Guidelines ... #Treatment
Xa Inhibitors - Apixaban and Rivaroxaban 
Oral Xa inhibitors are recommended by CHEST as first-line for
patients with VTE treatment ... Here is an overview ... of the dosing schemes ... #Rivaroxaban #Dosing ... #Pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... Multi-Drug Resistant Tuberculosis ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... macrophages and T cells ... Treatment: Active ... Initiating Treatment ... Diagnosis #Management #Treatment
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
IDSA Summary of ... multidrug-resistant tuberculosis ... MultiDrugResistant #Tuberculosis ... antimicrobials #pharmacology ... #ebm #idsa
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... CD4 count <100 cells ... Penicilliosis #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... macrophages and T cells ... Treatment: Active ... Initiating Treatment ... Diagnosis #Management #Treatment
Anastrozole is a Selective non-steroidal aromatase Inhibitor. Used for the treatment of breast cancer in postmenopausal
Used for the treatment ... and in cancer cells ... #pharmacology #overview ... druginformation #treatment